The Beauty Health Company (NASDAQ:SKIN) Receives Consensus Rating of "Hold" from Analysts

Key Points

• Analysts rate Beauty Health “Hold” on average: Five of seven analysts recommend holding the stock, while one rates it a sell and one a buy. The average 12-month price target is $1.375, though several firms recently lowered their targets.
• Shares opened at $0.66, near the lower end of their 52-week range of $0.55 to $2.69. The company has a market capitalization of approximately $85.5 million and substantial leverage, with a debt-to-equity ratio of 4.36.
• Beauty Health met quarterly EPS expectations with a loss of $0.02 per share, but revenue of $72.09 million fell short of the $74.45 million consensus estimate. Institutional investors own 93.26% of the company’s stock.

The Beauty Health Company (NASDAQ:SKIN - Get Free Report) has earned an average recommendation of "Hold" from the seven ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and one has issued a buy recommendation on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $1.3750.

SKIN has been the subject of several analyst reports. Canaccord Genuity Group reduced their target price on Beauty Health from $1.50 to $1.00 and set a "hold" rating for the company in a report on Friday, May 1st. Zacks Research lowered shares of Beauty Health from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 20th. TD Cowen dropped their price objective on shares of Beauty Health from $1.00 to $0.90 and set a "hold" rating on the stock in a report on Wednesday. Weiss Ratings lowered shares of Beauty Health from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Thursday, July 23rd. Finally, Roth Capital reiterated a "buy" rating and issued a $2.00 target price (down from $2.50) on shares of Beauty Health in a research note on Wednesday, May 20th.

Institutional Trading of Beauty Health

Several institutional investors have recently modified their holdings of SKIN. Capricorn Fund Managers Ltd bought a new position in Beauty Health in the first quarter worth $17,270,000. Diversified Trust Co bought a new stake in Beauty Health in the 1st quarter valued at $25,000. MTM Investment Management LLC raised its stake in shares of Beauty Health by 114.0% in the 4th quarter. MTM Investment Management LLC now owns 26,218 shares of the company's stock valued at $36,000 after buying an additional 13,968 shares in the last quarter. CWM LLC raised its position in Beauty Health by 232.8% in the fourth quarter. CWM LLC now owns 22,018 shares of the company's stock worth $31,000 after purchasing an additional 15,402 shares in the last quarter. Finally, SG Americas Securities LLC lifted its holdings in shares of Beauty Health by 111.9% during the fourth quarter. SG Americas Securities LLC now owns 24,670 shares of the company's stock valued at $34,000 after acquiring an additional 13,026 shares during the period. Institutional investors and hedge funds own 93.26% of the company's stock.

Beauty Health Stock Up 2.0%

SKIN opened at $0.66 on Friday. The company has a market capitalization of $85.54 million, a PE ratio of -3.00 and a beta of 1.07. The business has a 50-day moving average of $0.73 and a 200-day moving average of $0.89. The company has a debt-to-equity ratio of 4.36, a current ratio of 1.76 and a quick ratio of 1.48. Beauty Health has a fifty-two week low of $0.55 and a fifty-two week high of $2.69.

Beauty Health (NASDAQ:SKIN - Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported ($0.02) EPS for the quarter, hitting the consensus estimate of ($0.02). Beauty Health had a negative net margin of 9.79% and a negative return on equity of 47.83%. The company had revenue of $72.09 million during the quarter, compared to the consensus estimate of $74.45 million. Equities research analysts forecast that Beauty Health will post -0.16 EPS for the current fiscal year.

About Beauty Health

Beauty Health Company NASDAQ: SKIN is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health's brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source